Item 16. Form 10-K Summary
5K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
Not applicable.
Table of Content
SIGNATURES
Pursuant to the requirements of the Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MODERNA, INC. | |||||||||||
| Date: | By: | /s/ Stéphane Bancel | |||||||||
| February 25, 2022 | |||||||||||
| Stéphane Bancel | |||||||||||
| Chief Executive Officer and Director | |||||||||||
Table of Content
POWER OF ATTORNEY AND SIGNATURES
Each individual whose signature appears below hereby constitutes and appoints each of Stéphane Bancel and David Meline and as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /s/ Stéphane Bancel | Chief Executive Officer and Director (Principal Executive Officer) | February 25, 2022 | ||||||||||||
| Stéphane Bancel | ||||||||||||||
| /s/ David Meline | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | February 25, 2022 | ||||||||||||
| David Meline | ||||||||||||||
| /s/ Noubar B. Afeyan, Ph.D. | Chairman and Director | February 25, 2022 | ||||||||||||
| Noubar B. Afeyan, Ph.D. | ||||||||||||||
| /s/ Stephen Berenson | Director | February 25, 2022 | ||||||||||||
| Stephen Berenson | ||||||||||||||
| /s/ Sandra Horning, M.D. | Director | February 25, 2022 | ||||||||||||
| Sandra Horning M.D. | ||||||||||||||
| /s/ Robert Langer, Sc.D. | Director | February 25, 2022 | ||||||||||||
| Robert Langer, Sc.D. | ||||||||||||||
| /s/ Francois Nader, M.D. | Director | February 25, 2022 | ||||||||||||
| Francois Nader M.D. | ||||||||||||||
| /s/ Elizabeth Nabel, M.D. | Director | February 25, 2022 | ||||||||||||
| Elizabeth Nabel, M.D. | ||||||||||||||
| /s/ Paul Sagan | Director | February 25, 2022 | ||||||||||||
| Paul Sagan | ||||||||||||||
| /s/ Elizabeth Tallett | Director | February 25, 2022 | ||||||||||||
| Elizabeth Tallett | ||||||||||||||
Previous: Item 15. Exhibits, Financial Statement Schedules